by Roger Tristram | Nov 19, 2017 | Uncategorised
What’s new? US based biotechnology company appoints BRC A global US corporation, involved in the development and manufacture of therapies to combat serious neurological, autoimmune and rare diseases, approached BRC with a view to exploring the benefits of a best...